| Financial Year |
March 31 2023 |
| Monetary Funds |
3,580,119,678.67 |
| Held-for-trading Financial Assets |
609,369,474.48 |
| Notes Receivable |
13,996,752.12 |
| Accounts Receivable |
873,121,677.50 |
| Advances to Suppliers |
99,005,445.07 |
| Other Receivables |
882,936,621.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
9,366,788.13 |
| Dividend Receivable |
-- |
| Inventories |
768,615,385.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,298,222.19 |
| Total Current Assets |
6,863,666,189.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
320,233,565.69 |
| Investment Properties |
262,983,485.00 |
| Fixed Assetes |
1,646,800,286.22 |
| Under-construction Projects |
124,792,777.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
858,887.61 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
490,694,247.00 |
| R&D expenses |
58,407,746.81 |
| Goodwill |
320,004,109.06 |
| Long-Term Deferred and Prepaid Expenses |
48,562,582.01 |
| Deferred Income Tax Assets |
146,354,020.29 |
| Other Non-Current Assets |
60,942,720.05 |
| Sub-Total of Non-Current Assets |
4,817,941,519.52 |
| Total Assets |
11,681,607,709.04 |
| Short-Term Loans |
1,040,592,199.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
465,328.80 |
| Accounts Payable |
555,615,833.75 |
| Accounts Received In Advance |
9,178,006.38 |
| Employee Compensation Payable |
44,906,027.04 |
| Taxes Payable |
69,862,730.39 |
| Interest Payable |
127,786.14 |
| Dividend Payable |
2,388,105.45 |
| Other payables |
643,563,711.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
170,500,186.15 |
| Other Current Liabilities |
13,819,967.08 |
| Sub-Total of Current Liabilities |
2,588,478,537.62 |
| Long-term Loans |
637,222,873.26 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,666,709.50 |
| Other Non-Current Liabilities |
10,434,750.06 |
| Sub-Total of Non-Current Liabilities |
860,788,243.43 |
| Total Liabilities |
3,449,266,781.05 |
| Paid-In Capital(Or Share Stock) |
3,468,733,704.00 |
| Capital Surplus |
14,544,932.79 |
| Surplus Reserve |
737,939,995.89 |
| LESS:Treasury Stock |
79,174,177.54 |
| Undistributed Profits |
2,348,338,762.70 |
| Minority Stockholder's Interest |
1,759,395,978.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,472,944,949.16 |
| Owner's Equity（Stockholder's Equity） |
8,232,340,927.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,681,607,709.04 |
